Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-07-25 Sale |
2024-07-26 9:22 pm |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
75,000 | $1.3217 | $99,125 | 4,354,449 (Direct) |
View |
2024-05-10 Sale |
2024-05-14 9:13 pm |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
658,809 | $1.2181 | $802,495 | 4,429,449 (Direct) |
View |
2024-03-21 Sale |
2024-03-25 9:45 pm |
SPRUCE BIOSCIENCES INC. | SPRB | Novo Holdings A/S 10% Owner |
465,021 | $0.7547 | $350,951 | 2,550,000 (Direct) |
View |
2024-03-18 Sale |
2024-03-20 8:56 pm |
SPRUCE BIOSCIENCES INC. | SPRB | Novo Holdings A/S 10% Owner |
1,794,999 | $0.75699 | $1,358,804 | 3,015,021 (Direct) |
View |
2024-03-14 Sale |
2024-03-18 9:14 pm |
SPRUCE BIOSCIENCES INC. | SPRB | Novo Holdings A/S 10% Owner |
1,912,316 | $0.8884 | $1,698,902 | 4,810,020 (Direct) |
View |
2024-02-09 Purchase |
2024-02-15 8:38 pm |
Metagenomi Inc. | MGX | Novo Holdings A/S 10% Owner |
900,000 | $14.47 | $13,025,000 | 1,739,175 (Direct) |
View |
2024-02-09 Sale |
2024-02-13 9:31 pm |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
658,809 | $1.5003 | $988,411 | 5,088,258 (Direct) |
View |
2023-08-09 Purchase |
2023-08-11 4:31 pm |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
2,469,135 | $2.025 | $4,999,998 | 8,176,602 (Direct) |
View |
2023-07-19 Sale |
2023-07-20 8:01 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
101,900 | $2.7516 | $280,387 | 3,522,136 (Direct) |
View |
2023-07-14 Sale |
2023-07-18 8:27 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
38,600 | $2.7467 | $106,024 | 3,624,036 (Direct) |
View |
2023-06-30 Sale |
2023-07-03 6:29 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
200,937 | $2.6341 | $529,288 | 3,662,636 (Direct) |
View |
2023-06-26 Sale |
2023-06-28 9:35 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
40,415 | $1.7764 | $71,794 | 3,863,573 (Direct) |
View |
2023-06-28 Sale |
2023-06-28 5:04 pm |
Disc Medicine Inc. | IRON | Novo Holdings A/S 10% Owner |
1,250,000 | $46.1 | $57,625,000 | 1,090,772 (Direct) |
View |
2023-06-21 Sale |
2023-06-23 7:17 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
13,298 | $1.9454 | $25,870 | 3,903,988 (Direct) |
View |
2023-06-23 Sale |
2023-06-23 7:15 pm |
Reneo Pharmaceuticals Inc. | RPHM | Novo Holdings A/S 10% Owner |
100,000 | $7.0974 | $709,740 | 3,330,337 (Direct) |
View |
2023-06-15 Sale |
2023-06-20 5:53 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
16,729 | $2.0335 | $34,019 | 3,917,286 (Direct) |
View |
2023-06-12 Sale |
2023-06-14 8:18 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
6,398 | $2.098 | $13,423 | 3,934,015 (Direct) |
View |
2023-02-16 Purchase |
2023-02-21 4:19 pm |
SPRUCE BIOSCIENCES INC. | SPRB | Novo Holdings A/S 10% Owner |
2,208,000 | $3.17 | $6,999,360 | 8,378,336 (Direct) |
View |
2022-09-14 Purchase |
2022-09-16 2:35 pm |
Edgewise Therapeutics Inc. | EWTX | Novo Holdings A/S 10% Owner |
484,496 | $10.32 | $4,999,999 | 6,071,703 (Direct) |
View |
2022-07-20 Sale |
2022-07-22 6:52 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
900,000 | $3 | $2,700,000 | 3,940,413 (Direct) |
View |
2022-07-13 Sale |
2022-07-15 4:16 pm |
Bolt Biotherapeutics Inc. | BOLT | Novo Holdings A/S 10% Owner |
800,000 | $2 | $1,600,000 | 3,703,991 (Direct) |
View |
2022-02-23 Sale |
2022-02-25 6:21 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Novo Holdings A/S 10% Owner |
8,110 | $2.8443 | $23,067 | 2,161,990 (Direct) |
View |
2022-02-08 Purchase |
2022-02-09 5:42 pm |
Arcellx Inc. | ACLX | Novo Holdings A/S 10% Owner |
833,333 | $15 | $12,499,995 | 4,016,878 (Direct) |
View |
2021-11-09 Purchase |
2021-11-10 7:04 pm |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
325,000 | $14 | $4,550,000 | 3,277,932 (Direct) |
View |
2021-10-26 Purchase |
2021-10-27 4:31 pm |
MINERVA SURGICAL INC | UTRS | Novo Holdings A/S 10% Owner |
580,000 | $12 | $6,960,000 | 2,057,132 (Direct) |
View |
2021-06-22 Purchase |
2021-06-23 5:18 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
277,777 | $18 | $4,999,986 | 4,840,413 (Direct) |
View |
2021-06-21 Purchase |
2021-06-22 5:17 pm |
Verve Therapeutics Inc. | VERV | Novo Holdings A/S 10% Owner |
350,000 | $19 | $6,650,000 | 793,265 (Direct) |
View |
2021-06-02 Sale |
2021-06-03 7:21 pm |
Inogen Inc | INGN | Novo Holdings A/S 10% Owner |
680,000 | $57.32 | $38,977,600 | 2,079,320 (Direct) |
View |
2021-05-19 Sale |
2021-05-21 4:32 pm |
SPRUCE BIOSCIENCES INC. | SPRB | Novo Holdings A/S 10% Owner |
475,000 | $13.9 | $6,602,500 | 4,514,336 (Direct) |
View |
2021-04-13 Purchase |
2021-04-14 4:44 pm |
Reneo Pharmaceuticals Inc. | RPHM | Novo Holdings A/S 10% Owner |
666,666 | $15 | $9,999,990 | 3,430,377 (Direct) |
View |
2021-03-30 Purchase |
2021-03-31 4:36 pm |
Edgewise Therapeutics Inc. | EWTX | Novo Holdings A/S 10% Owner |
625,000 | $16 | $10,000,000 | 5,587,207 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-02-13 Conversion |
2024-02-15 8:38 pm |
N/A N/A |
Metagenomi Inc. | MGX | Novo Holdings A/S 10% Owner |
1,678,350 | $0 | 1,739,175 (Direct) |
View |
Ownership |
2024-02-08 8:37 pm |
N/A N/A |
Metagenomi Inc. | MGX | Novo Holdings A/S 10% Owner |
0 | $0 | 839,175 (Direct) |
View |
Ownership |
2023-01-03 4:42 pm |
N/A N/A |
Disc Medicine Inc. | IRON | Novo Holdings A/S 10% Owner |
0 | $0 | 2,340,772 (Direct) |
View |
2022-02-08 Conversion |
2022-02-09 5:42 pm |
N/A N/A |
Arcellx Inc. | ACLX | Novo Holdings A/S 10% Owner |
6,367,090 | $0 | 4,016,878 (Direct) |
View |
Ownership |
2022-02-03 6:04 pm |
N/A N/A |
Arcellx Inc. | ACLX | Novo Holdings A/S 10% Owner |
0 | $0 | 3,183,545 (Direct) |
View |
2021-11-09 Conversion |
2021-11-10 7:04 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
3,245,306 | $0 | 3,277,932 (Direct) |
View |
Ownership |
2021-11-04 5:15 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
0 | $0 | 2,952,932 (Direct) |
View |
2021-10-26 Conversion |
2021-10-27 4:31 pm |
N/A N/A |
MINERVA SURGICAL INC | UTRS | Novo Holdings A/S 10% Owner |
7,027,192 | $0 | 2,057,132 (Direct) |
View |
Ownership |
2021-10-21 7:33 pm |
N/A N/A |
MINERVA SURGICAL INC | UTRS | Novo Holdings A/S 10% Owner |
0 | $0 | 1,477,132 (Direct) |
View |
2021-06-22 Conversion |
2021-06-23 5:18 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
20,115,752 | $0 | 4,840,413 (Direct) |
View |
2021-06-21 Conversion |
2021-06-22 5:17 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Novo Holdings A/S 10% Owner |
443,265 | $0 | 793,265 (Direct) |
View |
Ownership |
2021-06-17 9:43 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
0 | $0 | 4,562,636 (Direct) |
View |
Ownership |
2021-06-16 5:18 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Novo Holdings A/S 10% Owner |
0 | $0 | 443,265 (Direct) |
View |
2021-04-13 Conversion |
2021-04-14 4:44 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Novo Holdings A/S 10% Owner |
15,130,765 | $0 | 3,430,377 (Direct) |
View |
Ownership |
2021-04-08 5:57 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Novo Holdings A/S 10% Owner |
0 | $0 | 2,763,711 (Direct) |
View |
2021-03-30 Conversion |
2021-03-31 4:36 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Novo Holdings A/S 10% Owner |
9,924,414 | $0 | 5,587,207 (Direct) |
View |
Ownership |
2021-03-25 8:34 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Novo Holdings A/S 10% Owner |
0 | $0 | 4,962,207 (Direct) |
View |